Alzheimer’s drug, FDA approved a new one
The U.S. Food and Drug Administration on Friday approved a second Alzheimer’s drug, lecanemab, despite reports of rare brain bleeds
Read More
Helal Medical Manila
Helal Medical Manila
The U.S. Food and Drug Administration on Friday approved a second Alzheimer’s drug, lecanemab, despite reports of rare brain bleeds
Read More